milodistim
Term · Oncology and biomedicine · MLC-T-ONC-015186
A recombinant fusion protein derived from the coding sequences of two growth factors, interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF). Milodistim exhibits greater receptor binding affinity and colony stimulating activity than its parent cytokines. This agent stimulates proliferation of immature hematopoietic cells and allows the stimulation and expansion of multi-lineage hematopoiesis from immature bone marrow progenitor cells.
| Identifier | MLC-T-ONC-015186 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | pixykine; GM-CSF/IL-3 Fusion Protein; GM-CSF/IL3 Fusion Protein; Granulocyte-Macrophage Colony Stimulating Factor/Interleukin-3 Fusion Protein |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015186",
"term": "milodistim",
"field": "Oncology and biomedicine",
"definition": "A recombinant fusion protein derived from the coding sequences of two growth factors, interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF). Milodistim exhibits greater receptor binding affinity and colony stimulating activity than its parent cytokines. This agent stimulates proliferation of immature hematopoietic cells and allows the stimulation and expansion of multi-lineage hematopoiesis from immature bone marrow progenitor cells.",
"synonyms": [
"pixykine",
"GM-CSF/IL-3 Fusion Protein",
"GM-CSF/IL3 Fusion Protein",
"Granulocyte-Macrophage Colony Stimulating Factor/Interleukin-3 Fusion Protein"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/milodistim/"
}
Record 11,064 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.